State-of-the-Art Facilities
Our facility meets the highest safety standards, ensuring a safe and controlled environment for all manufacturing processes.
Biopharmaceutical
Production Facilities
Our Biosafety Level 2 facility adheres to strict safety protocols, handling biologics and novel modalities with precision. We are Health Canada approved and compliant with US and EMEA FDA regulations, ensuring high standards and market readiness. Utilizing advanced technologies, we support diverse applications, from therapeutics to gene therapy.
Montreal Facility
Montreal campus is our approximately 180,000 square feet Biosafety Level 2 facility, built to support clinical and commercial production of up to four products simultaneously.

India Facility
This facility in India will provide comprehensive solutions for pharmaceutical and biotechnology companies, covering everything from drug development to commercial manufacturing, to meet the global demand for these services.

Our Montreal Facility has 7,500L total capacity, with 2 large-scale suites and two backup suites, all with in-suite upstream and downstream processing.

Biosafety Level 2
Our facility operates at Biosafety Level 2, ensuring stringent safety protocols and a controlled environment.
Dedicated Production Areas
Separate Production Areas from Quality Control Labs, Warehouses, and Other Facility Zones
Advanced Manufacturing Technologies
Our advanced capabilities support various applications, including therapeutics, diagnostics, and gene therapy.
Health Canada Approved
We are proud to be Health Canada approved, demonstrating our commitment to meeting high regulatory standards.
US and EMEA FDA Compliant
Our compliance with US and EMEA FDA regulations highlights our dedication to maintaining international standards.